PremiumCompany AnnouncementsCK Life Sciences Reports 2024 Loss Amid Increased R&D Investment CK Life Sciences Announces Board Composition and Committee Roles CK Life Sciences Converts Loan into Equity in Strategic Debt Exchange PremiumCompany AnnouncementsCK Life Sciences’ Halneuron Gains FDA Fast Track CK Life Sciences Reports Profit Plunge, Advances Trials CK Life Sciences Anticipates Profit Drop